This is a precautionary signal, not an established risk
However, there was progress in the UK where the government announced Scotland CardioMetabolic Impact Study (SCoMIS) , a pioneering Real-World study, which will provide Wegovy to between 3,000-5,000 people living with Obesity in Scotlands poorest areas free of charge during a three year study [11] Despite FDA phasing out enforcement discretion that allowed GLP-1 compounding during shortages - and setting May 2025 deadlines for compounding to cease - compounding has continued beyond this deadline [12]
Older adults are another group
Eli Lillys patents on tirzepatide dont begin to expire until 2036
Science 375 , 671677 (2022)
GLP-1s help reduce oxidative stress in your cells, especially in belly fat, which is a key area of inflammation for women with PCOS